BEE-spoke-data/govdocs1-by-extension huggingface dataset:
> ![](media/image1.jpeg){width="0.8298611111111112in"
> height="0.7861111111111111in"}

**Agenda -- Day 1**

**May 23, 2006**

Registration 8:00 -- 8:15 Group

Welcome and Introductions 8:15 -- 8:30 Fay Rurup, Manager

Products & Initiatives Branch

**Payments Application Modernization (PAM)** 8:30 -- 9:30 Jesse Chavez

**Projects** Kansas City Financial Center

**International Treasury Services (ITS)** 9:30 -- 10:00 Michelle LaCome

San Francisco Financial Center

*Morning Break 10:00 -- 10:15*

**Governmentwide Accounting (GWA) &** 10:15 -- 11:45 Keith Jarboe

**Account Statement** Information Resources

*Lunch 11:45 -- 12:45*

**US Debit Card** 12:45 -- 1:45 Nick Arena

> *JP Morgan Chase*

**Fedwire Compliance** 1:45 -- 2:15 Michelle LaCome

Domestic/Foreign Payments San Francisco Financial Center

*Afternoon Break 2:15 -- 2:30*

**Treasury's General Account Deposit** 2:30 -- 3:30 Don Clark

**Reporting Network (TGAnet)** Federal Finance

**FMS Collections Architecture** 3:30 -- 3:55 Peter Moore

Federal Finance

**Closing Remarks** 3:55 - 4:00 Group

![](media/image1.jpeg){width="0.8298611111111112in"
height="0.7861111111111111in"}

**Agenda -- Day 2**

**May 24, 2006**

**Treasury Check Information System (TCIS)** 8:00 -- 9:00 Dawn
Johns/Michel Spratley

Financial Operations

**TGA.net -- Open Forum Session** 9:00 -- 9:30 Don Clark Federal Finance

**Breakout Session: Partnerships for Success** 9:30 -- 10:00 Group

San Francisco Financial Center

*Morning Break 10:00 -- 10:15*

**Breakout Session:** *Results* 10:15 -- 10:45 Group

San Francisco Financial Center

**Pay.gov** 10:45 -- 11:15 Peter Moore

Federal Finance

**Internet Cancellations** 11:15 -- 11:45 Rick Corrigan

San Francisco Financial Center

*Lunch 11:45 -- 12:45*

**Debt 101** 12:45 -- 1:45 Horace Tate

Debt Management Services

*Afternoon Break 1:45 -- 2:00*

**Paper Check Conversion (PCC)** 2:00 -- 2:45 Michelle LaCome

**Over-the-Counter (OTC)** San Francisco Financial Center

Electronic Evaluation 2:45 -- 3:00 Group

> ***Thank you!***
**Intelligent Design -- Poor Science, Poor Theology, Great Public
Appeal: How to Respond to the Perfect Storm?**

Connie Bertka

*Science and Policy Programs*

*American Association for the Advancement of Science*

*1200 New York Avenue, NW*

*Washington, DC 20005*

*UNITED STATES*

<cbertka@aaas.org>

Recently, a federal district court judge ruled that the attempts of a
Dover Pennsylvania school board to promote the teaching of intelligent
design in a high school science classroom violated the establishment
clause. To the great relief of scientists and science educators across
this country, the judge recognized ID as a religious view and not a
scientific theory. Even before the judge's ruling, the citizens of Dover
Pa ousted the school board that got them into the lawsuit to begin with.
The outcome of the first ever court case on Intelligent Design in this
country can be recorded as a confirmation of teaching science in the
science classroom.

Unfortunately, advocates of sound science education are still faced with
the reality that nearly half of Americans do not accept that humans and
other living things have evolved over time, intelligent design will
continue to appeal to those looking for an alternative to evolution, and
legislation continues to be introduced to "teach the weaknesses of
evolution." Will this ever end? Perhaps not, at least not until the
scientific community discovers new avenues for working with religious
communities to sort out the appropriate roles and relationships between
science and religion is this country. I will discuss the ID movement
from the context of both science and religion and possible relations
between them, and suggest strategies for promoting sound science
education. Good court decisions are a good start, now what? Astrobiology
explores the origin, extent, and future of life, is there a role,
especially, for astrobiologists to play in working with the public on
this issue?
![](media/image1.png){width="1.4590277777777778in"
height="0.7805555555555556in"}
![](media/image2.png){width="1.4604166666666667in"
height="0.9604166666666667in"}

NUTRIENT SAMPLE\
ANSWER SHEET

# Constituent Lab Value Meth Code SRS ID\_\_\_\_\_\_

Amm + OrgN as N mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_ **Lab
ID\_\_\_\_\_\_**

Ammonia as N mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_

Nitrate as N mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_

Nitrite + Nitrate as N mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_

Orthophosphate as P mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_

Total Nitrogen as N mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_

Total Phosphorus as P mg/L \_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_

> Analytical Methods and Codes

# Method Code

## Other 0

Atomic absorption: direct, air 1

Atomic absorption: direct, nitrous oxide 2

Atomic absorption: graphite furnace 3

Inductively coupled plasma 4

Direct current plasma 5

Inductively coupled plasma / mass spectrometry 6

Ion chromatography 7

Atomic absorption: cold vapor 8

Atomic fluorescence 9

Atomic absorption: extraction 10

Atomic absorption: hydride 11

Flame emission 12

Titration: colorimetric 20

Titration: electrometric 21

Colorimetric 22

Ion selective electrode 40

Electrometric (pH and specific conductance) 41

Gravimetric 50

Turbidimetric 51
> ***FOR IMMEDIATE RELEASE***
>
> June 13, 2005
>
> Press office: +389 (0)2 308-0446
>
> Cell phone: +389 (0)70 323-807
>
> Email: <talbor@usaid.gov>
>
> www.usaid.org.mk

PRESS RELEASE

Local wine producers off to California in export drive

[Skopje]{.underline} - Eight local wine producers who are participating
in USAID's Competitiveness project are off to California to participate
in an intensive three week course. The goal of the training is to
prepare Macedonian wine producers to compete in the world market.

The group leaves today (10 July 2005 ) and will be based at the the
Viticulture and Enology Department, University of California Davis, USA.

USAID will fund the travel and training which will cover industry
demand, production and regulation; marketing and sales focused on brand
establishment and management; and grape supply and economics of
production as well as winery cost-benefit analysis.

"The balanced combination of in-house and field training will give us
exposure to practices applied by the US wineries and further stimulate
individual adjustments resulting in future growth."- said Marija Miteva,
head of commercial department at Skovin wine cellar.

Targeting sales and marketing departments, the course will enable winery
staffs lead the capacity building efforts within wineries, helping them
to compete more successfully in the foreign markets and increase bottled
wine export revenue.

NOTES TO EDITORS:

[Participants]{.underline}:

-   Kire Andov-- Owner, Pivka Winery, Negotino;

-   Jani Bogevski -- Marketing Manager, Bovin Winery, Negotino;

-   Petar Danov -- Commercial Manager, Ezimit Vino Winery;

-   Divna Jordanovska - Manager, Cekorovi Winery, Kavadarci;

-   Marija Miteva -- Head of Commercial Department, Skovin Winery,
    Skopje;

-   Miro Popov -- Sales Manager, Vin Art Winery , Skopje;

-   Stefan Trajkoski -- Export Specialist, Fonko Winery, Skopje; and,

-   Sonja Velkovska -- Manager, Eno-Mak, Skopje.

[The Viticulture & Enology Department at US Davis:]{.underline} is the
world leader in combining the sciences of viticulture and enology in a
single research and teaching unit that encompasses all of the scientific
disciplines that impact grape growing and winemaking. For over one
hundred years the University of California has maintained an active and
productive program in research and education in viticulture and enology.

[United States Agency for International Development
(USAID):]{.underline} Since 1993, the American people, through USAID
have provided more than \$400 million in development assistance to
Macedonia to modernize schools, water supply systems and for other local
priorities. USAID has helped create new sources of financing for
business and has helped citizens get government services more easily.
USAID provides economic and humanitarian assistance in more than 100
countries to provide a better future for all.
November 23, 2005

Stephen A.J. Eisenberg, General Counsel

Pentagon Federal Credit Union

Post Office Box 1432

Alexandria, Virginia 22312-2032

Re: Credit Union Service Organization (CUSO) Investments in Non-CUSO
Service Providers.

Dear Mr. Eisenberg:

You have asked whether a CUSO may purchase and own shares of a closely
held title insurance agency as a permissible CUSO activity. No, a CUSO
may only invest in a non-CUSO service provider if its investment is
necessary to receive the non-CUSO's services or a reduced price for
goods or services.

Specifically, you have asked if your client's CUSO, established to offer
real estate brokerage services to the credit union's members, may
acquire twenty percent of the outstanding issued shares in a title
insurance agency (the agency). You assert the investment is a
permissible CUSO activity because the dividend income from the agency
shares is ultimately returned to the credit union through the CUSO,
enabling the credit union to defray its members' title insurance costs.

In connection with providing a permissible service, a CUSO may invest in
a non-CUSO service provider, if the amount invested is limited to the
"amount necessary to participate in the service provider, or a greater
amount if necessary to receive a reduced price for goods or services."
12 C.F.R. §712.5(r). For instance, a CUSO may buy stock in an
ATM-network in order to make the network available to members of its
participating credit unions. 63 Fed. Reg. 65714, 65715 (Nov. 30, 1998).
In the facts presented, it is not necessary for the CUSO to acquire any
amount of shares in the agency before it can obtain the agency's
services. Furthermore, there is no evidence the agency reduces the price
of its services for shareholders. The CUSO, therefore, may not make the
investment in the agency as a permissible CUSO activity.

Sincerely,

Sheila A. Albin

Associate General Counsel

GC/CJL:bhs

05-1018
# **Nonactinide Isotopes & Sealed Sources**

# **Management Group (NISSMG)**

# ![](media/image1.png){width="1.5104166666666667in" height="1.0520833333333333in"}

# **Nonactide Isotopes and Sealed Sources** 

# **Material Management Group**

# **Brookhaven National Laboratory - 50 Curie Neutron Source**

# 

# 

# 

# **Complex--Wide Resources**

# **Solving Site Specific Problems**

At our meeting on June 14, 2001, BNL identified a 50 curie Am/Be neutron
source that must be removed from its current location at the Building
445 yard. Removing this source is a critical path item for BNL to meet
it's commitment of down grading the Building 445 yard from a nuclear
storage area to a radiological area, thus allowing the CERCLA soil
remediation action to begin as scheduled in FY-02. You also advised us
that you were pursuing disposal via the Off Site Recovery Project
(OSRP), but their schedule to remove the source probably would not
support BNL's CERCLA commitment.

The NISSMG suggested that BNL continue to work with the OSRP program for
permanent disposal of the neutron source, and the NISSMG committed to
identifying interim storage options at other DOE sites that would allow
BNL to meet its CERCLA commitment.

Since our meeting the NISSMG has contacted Carl Ahlberg at DOE-CH to
determine the viability of interim storage at ANL-W in Idaho. ANL-W has
ample storage capability and has recently assisted FERMI Lab by
providing interim storage for FERMI Pu/Be neutron sources. Carl stated
that ANL-W indeed was a possibility, however Carl believes that as this
neutron source is an Am/Be, and there are no security issues associated
with storage, that FERMI Lab could possibly provide interim storage.

For BNL to pursue either of these options the next step is to contact
Carl Ahlberg at DOE-CH. His phone number is (630) 252-2068 and his
e-mail address is <carl.ahlberg@ch.doe.gov>.

As the NISSMG understands it, this Am/Be neutron source previously
leaked but has been successfully repaired at BNL. It still may require
repackaging into a "special form" container before it can be shipped. If
BNL needs assistance in obtaining a suitable container and/or shipping
plans the NISSMG will gladly continue to support BNL by providing
technical support.
Poster #2

**Maternal Diet Influences Fetal Thyroid Function and Chromatin
Remodeling Complexes in a Primate Model of Obesity**

[K. Aagaard-Tillery^1^]{.underline}, M. Suter^1^, P. Bocock^1^, R.
Harris^1^, S. Williams^2^, H. Sangi-Haghpeykar^1^, K. Grove^2^, and R.
Lane^3^

^1^Department of Obstetrics and Gynecology, Baylor College of Medicine,
Houston, TX; ^2^Oregon National Primate Research Center, Oregon Health
and Science University, Beaverton, OR; ^3^Department of Pediatrics,
University of Utah, Salt Lake City, UT

Hypothyroidism is associated with the development of obesity and
dyslipidemia. Emerging evidence suggests that thyroid receptor
associated proteins (TRAP) are key regulatory components of chromatin
remodeling complexes. Our prior studies demonstrate that an high fat
(HF) maternal diet induces non-alcoholic steatohepatitis (NASH), while
epigenetically altering chromatin structure of reprogrammed fetal genes.
We hypothesized that a HF maternal diet influences the fetal thyroid and
TRAP expression, thereby setting the stage for obesity via alterations
in chromatin remodeling complexes. Pregnant macaques were fed a control
HF diet up to yr 4, with a subset reverted to control diet in yr 5. e130
serum/tissue of delivered maternal-offspring pairs in successive
gestations were obtained to assay thyroid hormones (TH: fT4, fT3, T3RU,
TBG), lipids/FFA, cortisol, and leptin. Correlation of fetal TH to lipid
levels was performed with Fishers ***z*** transformation in stratified
regression models. Consistent with marked disruption of fetal thyroxine
regulation, maternal and fetal fT4 became inversely correlated with HF
diet (r+.43, -.57, p \< .01), and adjusted fetal fT4 was significantly
less (1.97 vs. 1.34, p \< .0001). Moreover, while under the control
diet, adjusted fetal TH to lipids trended in an inverse correlation
(r-.09, -.6) and the HF diet reversed this correlation (r+.01, +.57)
with a modest restoration following gestational diet reversal (r-.02,
+.4). In Affymetrix (HG-U133 40K human genes) microarrays of fetal
hepatic tissue, TRAP3 alone bore significant differential expression (\>
4 0-fold) among thyroid-related genes. These data demonstrate that an
obese *in utero* environment alters both fetal thyroid levels and
correlative dyslipidemia in a reversible fashion, as well as hepatic
TRAP3. We speculate that this serves as a potential novel mechanistic
link relating development of obesity with fetal hypothyroidism, NASH,
chromatin-remodeling complexes, and gene-specific regulation.
PUGET SOUND GRECC FY 03 HIGHLIGHTS

I. Collaboration With Other VA Entities

-   Collaboration with Ming Tsuang, MD, PI (Boston VA) and VA
    Cooperative Study Unit on Schizophrenia

-   Noradrenergic activity in aging and Alzheimer's disease. A conjoint
    project with MIRECC (E. Peskind, PI)

-   Gerard Schellenberg PhD collaboration with VISN 20 PADRECC.

# II. Aging Research

-   Royalty Research Fund Award: Computer data-based projects to assess
    association between diagnosed hypogonadism and depression.

-   Noradrenergic activity in aging and Alzheimer's disease. This is a
    conjoint project with MIRECC.

-   Telemedicine project: to assess efficacy of diagnosing dementia via
    telemedicine.

-   Collaboration with Ming Tsuang (Boston VA) and VA Cooperative Study
    Unit on Schizophrenia.

-   Collaboration with Greg Cole, PhD (Sepulveda VA) on Alzheimer's
    disease and animal models.

-   NIH funded research on genetic factors in Alzheimer's disease,
    anti-inflammatory agents as potential therapeutic agents for
    Alzheimer's disease, role of insulin resistance in CNS aging and
    Alzheimer's disease.

-   NIH and industry funded research on generating animal models for
    neurodegenerative diseases.

-   Alzheimer's Disease Anti-inflammatory Prevention Trial: PI John
    Breitner, MD, MPH: Local site Coordinator Suzanne Craft, PhD

## III. Education and Training

-   New this year: 2-3 psychiatry residents work in the GRECC clinic
    every week under

> the supervision of the Geropsychiatry attending.

-   Weekly geropsychiatry conferences are held prior to the GRECC
    clinic. This conference is attended by psychiatry residents,
    geropsychiatry fellows, geriatric medicine fellows and AD research
    assistants.

-   A geropsychiatry didactics series for the UW psychiatry residents is
    organized and directed by GRECC faculty. Geriatric medicine fellows
    spend one month of their VA rotation on the geropsych consult
    service.

-   Weekly Alzheimer's disease journal club and clinical pathologic
    conference.

-   Seminar on "Transitional Research in Alzheimer's Disease: From the
    Bench to the Clinic."

-   Monthly Fellows Research Conference: Gives Fellows opportunity to
    present current research projects to senior faculty and staff.
    Provides outstanding opportunity for feedback and mentorship of
    fellows.

# IV. Clinical Demonstrations Models/Best Practices

-   Telemedicine "Can you diagnose dementia via telemedicine?"

-   Patient Education "Can patient satisfaction be improved by providing
    additional education?"

## V. Dissemination of GRECC Products

-   Once per month, aging related programs are shared via Vtel with all
    the facilities in VISN 20, and the State Veteran Homes.

-   Once per month September through March, a research and clinical
    seminar series for staff at UW and VAPSHCS

-   GRECC research activities have been presented at the annual AAGP
    meeting, the GSA meeting, and other major meetings around the
    country and around the globe.

-   GRECC investigators have publication in over 40 scientific journals.
**DA 06-1599**

**Released: August 7, 2006**

**NOTICE OF STREAMLINED DOMESTIC 214 APPLICATION GRANTED**

**WC Docket No. 06-128**

The application listed in this notice has been granted pursuant to the
Commission's streamlined procedures for domestic section 214 transfer of
control applications. 47 C.F.R. § 63.03. The Wireline Competition Bureau
has determined that grant of this application serves the public
interest.[^1] For purposes of computation of time for filing a petition
for reconsideration or application for review, or for judicial review of
the Commission's decision, the date of "public notice" shall be the
release date of this notice.[^2]

1.  Domestic Section 214 Application Filed for the Transfer of Control
    of Global Internetworking, Inc. to Mercator Partners Acquisition
    Corp., WC Docket No. 06-128, DA 06-1410 (rel. July 7, 2006)

> **Effective Date of Grant:** August 7, 2006

For further information, please contact Adam Kirschenbaum at (202)
418-7280, Competition Policy, Wireline Competition Bureau.

[^1]: *Implementation of Further Streamlining Measures for Domestic
    Section 214 Authorizations*, 17 FCC Rcd 5517, 5529, para. 22 (2002).

[^2]: *Id*.; *see* 47 C.F.R. § 1.4 (Computation of time).
**Setting the Coordinate System for an Image**

*If you are using imagery from another source, it may not align with
existing USDA data. To correct this, the coordinate system must be
identified in a way that ArcMap recognizes. These instructions show one
method of completing this. You [will]{.underline} need to learn what
coordinate system to use from the source of the data before performing
this process.*

1.  Start ArcCatalog![](media/image1.png)

2.  Navigate to the appropriate folder *(this will vary)*

3.  ![](media/image2.png)Right-click on image, and select **Properties**
    from the menu

4.  ![](media/image3.png){width="2.6354166666666665in"
    height="2.4166666666666665in"}In the Raster Dataset Properties
    window, click **Edit...\
    ***(If anything other than \<Undefined\> appears here, it may not be
    necessary to perform this process. Proceed [only]{.underline} if you
    have tried to use this imagery in conjunction with USDA imagery, and
    they don't align.)*

5.  ![](media/image4.png){width="1.8645833333333333in"
    height="2.9479166666666665in"}In the Spatial Reference Properties,
    click **Select**

6.  ![](media/image5.png){width="3.0701388888888888in"
    height="2.092361111111111in"}Browse to the appropriate coordinate
    system, and click **Add** *(this will vary)*:

![](media/image9.png){width="3.0729166666666665in"
height="2.0833333333333335in"}

7.  Click **OK** on the Spatial Reference Properties and Raster Dataset
    Properties dialogs.

8.  Repeat for other images as necessary.

9.  Close ArcCatalog.
February 5, 2001

Item: Magnetic Resonance Imaging (MRI) systems, all.

Specific Incident: A "sand bag" attached to a patient's arm undergoing
an MRI exam contained iron pellets (unknown to staff) encased in heavy
vinyl; brand name "North West". When the patient was being moved into
the MRI bore, the iron-filled bag flew into the magnet and pinned the
patient's forearm to the side of the magnet. Emergency measures were
used to turn the magnet off, and the patient was unharmed. **Sometimes,
"sand bags" = "iron bags".**

Recommendation: 1) Purchase "sand bags" for patient care that do not
contain iron (or only materials specified by the vendor to be used
safely). These bags should be labeled MRI-safe (i.e., intended for use
in *your specific MRI environment*)

> 2\) If your facility continues to use "sand-bags" for patient care
> that contain iron, those bags should be clearly labeled "Contains
> Iron: DO NOT expose to MRI"
>
> 3\) Patients should disrobe and wear clothing tested for your MRI
> environment

4\) DO NOT verify that a "sand-bag" is compatible by testing it with the
MRI magnet -- this could have catastrophic consequences

> 5\) Staff should consider all items to be unsafe for the MRI
>
> environment until "proven" otherwise. This could be done with a
> checklist, where each item is explicitly determined "safe" by
> manufacturer documentation and removal of any metal items

Additional Information: To better understand other potential hazards
with MRI systems, please see the "Supplemental MRI Hazard Summary" on
the NCPS Web site <http://vaww.ncps.med.va.gov/>. AND, please notify
NCPS ***if your facility has had close calls***, or you have discovered
***effective countermeasures***. Also see FDA guidance at
[www.fda.gov/cdrh/ode/primerf6.html](http://www.fda.gov/cdrh/ode/primerf6.html)

Source: John Gosbee, VHA Center for Patient Safety, 734-930-5890,
John.Gosbee@med.va.gov
Use style "Text" for informational text without step numbers.

[NOTE CAUTION WARNING]{.underline}\
USE STYLE "Note C&W" FOR NOTES, CAUTIONS, AND WARNINGS.

The purpose of this TPS is \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\...

NOTE: Dangerous \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ (ie. lifting,
electrical work, welding, cryogenics, gas filling) is required. Proper
CERN safety equipment and processes must be followed.

The \_\_\_\_\_\_\_\_\_\_\_\_\_ (NASA, JS, TRD,...) Project Engineer on
site has the option to reorder steps as required .

# Open this TPS

# All hardware removed during the performance of this TPS shall be bagged and tagged to identify their P/N and S/N or Lot# if applicable.

# Use "Heading 1" for numbered task steps.

## Use style "Heading 2" for numbered sub-steps.

![](media/image1.wmf)

### Use style "Heading 3" for lower level sub-steps.

# 

# 

# 

# Close this TPS. (this can be done when all numbered steps have been initialed by the tech performong the task and the MIP steps have been Stamped by the DV or NASA QA as required)
**[SCENARIO A]{.underline}**

**Mary, an English Language Fellow in Rokrainovia, is in her second year
as a Fellow. Her first year as a Fellow was in another country in
another region. When she began as a Fellow, her Regional Coordinator at
S.I.T. in Brattleboro actively handled all visa formalities for her.
When preparing for her new post in Rokrainovia, she'd heard nothing
about the visa, so she asked her new Regional Coordinator at the
pre-departure conference in Washington in August, where she was informed
that "visas are [always]{.underline} the responsibility of the Fellows."
She asked why there'd been a change in policy and why she wasn't
informed. It turned out that her first year qualified as a unique
situation; only in [that]{.underline} location were Fellows' visas taken
care of by S.I.T.**

**Mary asked other US expats in Rokrainovia, who gave her a variety of
responses about whether or not a visa was necessary. Shortly after
arriving at post, Mary noticed news reports saying that long-held but
unenforced visa rules were now going to be enforced. Without a visa,
Mary would be allowed a maximum stay in the country of 180 days, and
weekend border crossings to break up the long stay would not be
considered a valid way to avoid the need for a visa.**

**Mary asked her host institution but was told by them they could do
nothing as they do not legally employ her. They directed her to RELO.
RELO gave her the same response and was directed by them back to the
host institution. Mary contacted SIT, who informed her that obtaining a
visa is the Fellow's responsibility. Mary decided to take a chance that
her violation of the rules would not be discovered, and so did nothing
to obtain the visa.**

1)  **How could Mary have handled this more effectively from the
    start?**

2)  **What about the other parties in this situation? Do they have
    particular obligations here? If so, what are they?**

3)  **At this point, what advice do you have for Mary?**
Food and Drug Administration

**Center for Drug Evaluation and Research**

**Advisory Committee for Pharmaceutical Science**

**October 21-22, 2003**

Best Western Washington Gateway Hotel

1251 West Montgomery Avenue

Rockville, MD 20857

**Agenda**

**Day 1: Tuesday, October 21, 2003**

8:30 **Call to Order and Opening Remarks** Art Kibbe, Ph.D.

Chair, ACPS

###  **Introduction of Committee** 

**Conflict of Interest Statement** Hilda F. Scharen, M.S.

Executive Secretary, ACPS

8:45 **Introduction** Helen Winkle

> Director, Office of Pharmaceutical Science, CDER, FDA

***Subcommittee Reports***

9:00 **Manufacturing** Judy Boehlert, Ph.D.

> Chair, Manufacturing Subcommittee

**Clinical Pharmacology** Jürgen Venitz, M.D., Ph.D.

Chair, Clinical Pharmacology Subcommittee

***Draft PAT Guidance***

10:00 **Update** Ajaz Hussain, Ph.D.

> Deputy Director, Office of Pharmaceutical Science, CDER, FDA

**Questions/Discussion**

10:30 Break

***Parametric Tolerance Interval Test for Dose Content Uniformity***

10:45 **Overview and Issues** Ajaz Hussain, Ph.D.

> Deputy Director, Office of Pharmaceutical Science, CDER, FDA

11:30 **Open Public Hearing**

12:30 **Lunch**

1:30 **Approaches for resolving identified issues**

**IPAC-RS Presentations**

2:30 Break

2:45 **Committee Discussion and Recommendations**

4:30 **Adjourn**

Food and Drug Administration

**Center for Drug Evaluation and Research**

**Advisory Committee for Pharmaceutical Science**

**October 21-22, 2003**

Best Western Washington Gateway Hotel

1251 West Montgomery Avenue

Rockville, MD 20857

**Agenda**

**Day 2: Wednesday, October 22, 2003**

8:30 **Call to Order and Opening Remarks** Art Kibbe, Ph.D.

Chair, ACPS

###  **Introduction of Committee** 

**Conflict of Interest Statement** Hilda F. Scharen, M.S.

Executive Secretary, ACPS

> ***Risk-based CMC Review Proposals***

8:45 **Current Thinking**

**Focus on "process understanding"** Ajaz Hussain, Ph.D.

Deputy Director, Office of Pharmaceutical Science, CDER, FDA

**Issues and challenges**

**Committee Discussion**

10:15 **Break**

***Nomenclature***

10:45 **Proposals for resolving issues and challenges**

**FDA Perspective**

**Committee Discussion**

12:00 **Lunch**

1:00 **Open Public Hearing**

Food and Drug Administration

**Center for Drug Evaluation and Research**

**Advisory Committee for Pharmaceutical Science**

**October 21-22, 2003**

Best Western Washington Gateway Hotel

1251 West Montgomery Avenue

Rockville, MD 20857

**Agenda**

**Day 2: Wednesday, October 22, 2003 (Cont'd)**

***Research Plan for Generics -- Bioequivalence of Topical Products***

2:00 **Generic Drug Research Pogram**

**Dermatopharmacokinetics: Improvement of**

**methodology** **for assessing bioequivalence of**

**topical products**

> **Bioequivalence of topical products: FDA Perspective**

3:00 Break

3:15 **Committee Discussion**

4:45 **Conclusion and Summary Remarks** Ajaz Hussain, Ph.D.

Deputy Director, Office of Pharmaceutical Science, CDER, FDA

5:00 **Adjourn**
**The Loss of a Hero**

# Rep. Sue Myrick

In the 1960's and 1970's, America had lost its way. Americans no longer
trusted their elected leaders or the government. Americans forgot how
great America was, and how to believe in themselves. One man changed
America's feelings of self-doubt and despair to that of hope. The man
was Ronald Reagan.

President Reagan grew up in the small town of Dixon, Illinois. He lived
the American Dream, and told us we could live it too. He always spoke of
hope and a better tomorrow. He sprinkled his speeches with phrases like
"Morning in America" and "a shining city on a hill." He made us proud to
be Americans again.

Many called Reagan the "Great Communicator," but he humbly stated that
he merely communicated great ideas. As President, Reagan took a
stumbling economy and made it vibrant again. He believed that government
was not the solution, but was the problem. His policies of less
government and lower taxes helped revive American businesses and the
entrepreneurial spirit of America. And he did everything with style,
grace, and unforgettable humor.

President Reagan also restored honor and prestige to the Presidency
again. He was a man who stood upon rock solid values and called things
as he saw them.

When Reagan took office in 1980, we were in the midst of a stalemate
with the Soviet Union. Our policy was to neutralize and contain them.
Reagan had a different idea. He challenged them. He called them the
"evil empire." He told their leaders they could not beat the United
States. He told them to tear down the walls of Communism and allow
people to be free.

President Reagan's deep belief in freedom caused the end of the Cold War
in 1991. America had won and Reagan took the yoke of nuclear holocaust
off the back of the world. American children would no longer have to
hide under their desks in preparation for a nuclear war. American
families would no longer have to build bomb shelters. America and its
allies would no longer fear a Soviet attack. Reagan made the world safe,
and made America the world's sole superpower.

There are many great things to say about Reagan's Presidency, but there
are even more great personal stories about him. We will never forget his
deep, soulful, love for his wife. We will never forget his love of
jellybeans, of freedom, of his country, and his unfailing love for all
Americans. He was humble. He was kind. He was a hero when America needed
one most.

President Ronald Wilson Reagan passed away from us last week at age 93.
He is one of our greatest and most beloved Presidents. He will be
missed, but his legacy still lives. Millions of people around the world
enjoy freedom today because of President Reagan. The best way we can
honor him is to commit ourselves to make America that "shining city upon
a hill" he so often referred too.

May God bless President Reagan, and his family, and may he rest in
peace.
6510.2 REV-2

Paragraph Page

TABLE OF CONTENTS

CHAPTER 1. INTRODUCTION, DEFINITIONS,

AND GENERAL INSTRUCTIONS

1 - 1 Purpose 1

1 - 2 Background

1 - 3 Appendices 1

1 - 4 Narratives/Attachments 2

1 - 5 General Instructions 2

1 - 6 Recordkeeping Requirements 6

Appendices

1\. GPR Cover Sheet Instructions 1-1

Exhibit 1a: Example of Completed Cover Sheet 1-3

2\. Instructions for Completing Activity Summary 2-1

forms 4949.2 and 4949.2a

Exhibit 2a: National Objective Matrix 2-30

Exhibit 2b: Example of completed forms 2-33

for activities which are not

direct benefit activities

Exhibit 2c: Example of completed forms 2-38

with direct benefit activities

Exhibit 2d: Example of completed form 2-49

with unprogrammed balance

Exhibit 2e: Example of narrative for 2-50

displacement/tenant assistance/

relocation

Exhibit 2f: Example of a narrative for job 2-52

creation/retention activities

i 7/93

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

6510.2 REV-2

Exhibit 2g: Example of narrative on limited 2-53

clientele activity without

records or presumptive benefit

3\. Instructions for Completing Financial Summary, 3-1

form 4949.3

Exhibit 3a: Example of completed Financial 3-12

Summary

Exhibit 3b: Example of attachment for program 3-14

and other income, loans and

other receivables, reconciliation

of funds, and calculation of

unprogrammed funds

4\. Instructions for Completing One-for-One 4-1

Replacement Summary, form 4949.4

Exhibit 4a: Example of completed 4-4

One-for-One Replacement Summary

5\. Instructions for Completing Rehabilitation 5-1

Summary, form 4949.5

Exhibit 5a: Example of completed 5-7

Rehabilitation Summary

Exhibit 5b: Example of narrative of 5-8

completed rehabilitation

projects

6\. Instructions for Completing Displacement 6-1

Summary, form 4949.6

Exhibit 6a: Example of completed Displacement 6-4

Summary

7\. GPR Completeness Checklist 7-1

8\. Copies of GPR Forms 8-1

7/93 ii

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

6510.2 REV-2

GPR FORMS

FORM OMB CLEARANCE

NUMBER TITLE OF FORM NUMBER

4949.1 GPR Cover Sheet OMB No. 2506-0077

4949.2 Activity Summary OMB No. 2506-0077

4949.2a Activity Summary for OMB No. 2506-0077

Direct Benefit Activities

4949.3 Financial Summary OMB No. 2506-0077

4949.4 One-for-One Replacement OMB No. 2506-0077

4949.5 Rehabilitation Summary OMB No. 2506-0077

4949.6 Displacement OMB No. 2506-0077

iii 7/93
> DA 00-1236

June 6, 2000

# FCC Announces Expanded ULS Technical Support Hours

The Commission's Wireless Telecommunications Bureau announces expanded
hours for Universal Licensing System (ULS) technical support. ULS users
may now reach the FCC Technical Support Hotline by phone from 7 a.m. to
10 p.m. weekdays. Weekend service is newly available. On Saturdays that
Hotline will be open from 8 a.m. to 7 p.m., and on Sundays from 12 p.m.
to 6 p.m. See our revision of the standard ULS contact information below
for details on how to contact the Commission for ULS support. E-mail
queries to [ulscomm@fcc.gov]{.underline} will also be answered during
these expanded service hours.

The Commission continues to provide assistance with questions regarding
licensing requirements and ULS forms weekdays from 8 a.m. to 5:30 p.m.

The Commission listed the expanded hours in [Public Notice DA
00-1196](http://www.fcc.gov/wtb/uls/releases/da00-1196.doc) of June 1,
2000, which announced the June 2000 edition of Form 601 for electronic
filing via the ULS, without drawing specific attention to the fact that
the hours represented an increase in our customer service outreach. The
Technical Support Hotline now provides an additional 42 hours of
technical support weekly, for a total of 92 hours weekly. Customer
demand will determine whether there will be further changes to this
schedule.

Our standard contact information for ULS and certain other Commission
information now reads as follows:

**[FCC Technical Support Hotline]{.underline}**: 202-414-1250 (TTY 202-
414-1255), or via e-mail at [ulscomm@fcc.gov]{.underline}. Contact the
Technical Support Hotline about questions concerning computer access to
ULS, TIN registration, uploading files, or submitting attachments in
ULS. The hotline is available Monday through Friday, from 7 a.m. to 10
p.m., on Saturdays from 8 a.m. to 7 p.m., and Sundays from 12 p.m. to 6
p.m., all times Eastern Time. In order to provide better service to ULS
users and ensure the security of the electronic filing system, all calls
to the hotline are recorded.

**[ULS Licensing Support and Forms Information]{.underline}**:
1-888-CALLFCC (225-5322), choose option #2. E-mail questions may be sent
to [ulshelp@fcc.gov]{.underline}. Contact Licensing Support with
questions about which application purpose(s) are appropriate for a
particular filing, what information is being requested on a ULS form or
schedule, or any other ULS-related licensing matter. ULS Licensing
Support is available Monday through Friday, from 8:00 a.m. to 5:30 p.m.
Eastern Time.

**[Obtaining Forms]{.underline}**: The FCC offers several ways to obtain
forms. Forms can be acquired via the FCC forms page at
[http://www.fcc.gov/formpage.html;](http://www.fcc.gov/formpage.html)
via the Forms Request System (forms are mailed to those who request
them) at 1-800-418-FORM (3676); and via the Fax on Demand System at
202-418-0177.
![](media/image1.jpeg){width="3.0in" height="2.002083333333333in"}

LUNAR EXPLORATION SCIENCE WORKING GROUP

23rd General Meeting

The 23rd general meeting of LESWG (Lunar Exploration Science Working
Group) will be held on **Thurs, Nov 13th, 2008, at 10 AM, in B33,
H114**. All are welcome.

The purpose of LESWG is to exchange information about recent meetings
and proposal opportunities, and share ideas for GSFC lunar science
exploration efforts. At this meeting, the speakers are Mike Collier
(673) and Paul Lowman (698). Miike will discuss his winning LASER
proposal - "Lunar Potential Determination Using Apollo-Era Data and
Modern Measurements and Models". Paul has been involved in a project to
study lunar analogs and will present information on the Sudbury
Structure.

**Mike Collier (673) - "Lunar Potential Determination Using Apollo-Era
Data and Modern Measurements and Models"**

**Paul Lowman (698) -- " Sudbury Structure: Lunar Analogs"**

The web site for the "Lunar Focus Groups" and their points-of-contact
has been re-constituted, e.g., if people want to post focus group or
discipline-oriented activities.

General information about LESWG, as well as a previous presentations
from the earlier LESWG general meeting are available at the LESWG web
site

> (<http://ssedso.gsfc.nasa.gov/initiatives/lunar/>)

If you have questions about LESWG or the upcoming meeting, please
contact either Ed Grayzeck (<Edwin.J.Grayzeck@nasa.gov>) or Herb Frey
(<Herbert.V.Frey@nasa.gov>)
***PIH LETTER***

***L-2007-02***

**June 18, 2007**

## TO: Administrators, Offices of Native American Programs;

##  Tribal Government Leaders;

##  Tribally Designated Housing Entities 

**SUBJECT: Extension of Notice PIH 2007-57 -- Depository Agreements
for**

**Recipients of the Indian Housing Block Grant (IHBG) Program**

**CROSS**

**REFERENCES: PIH Notice 2005-23, PIH Notice 2006-28 (TDHEs)**

**Purpose.** This PIH Letter extends Notice PIH 2006-28 (TDHEs), which
transmits the current depository agreement forms to be used when
investigating IHBG funds; form HUD-52736A (10/2004) for banking accounts
and form HUD-52736B (10/2004) for brokers/dealers. Also, the Notice
clarifies when to use depository forms and when tribes or tribally
designated housing entities may utilize brokers in the investment of
Indian Housing Block Grant (IHBG) finds under 24 CFR 1000.58.

**Changes.** No changes were made to either Notice PIH 2005-23 or Notice
PIH 2006-28.

**For Further Information.** Questions regarding this letter may be
directed to Donna K. Jacobsen, Lead Grants Management Specialist, at
(303) 675-1618.

Sincerely,

[/S/]{.underline}

Orlando J. Cabrera, Assistant Secretary

for Public and Indian Housing
# SINUS INFECTION

**[What is a Sinus Infection]{.underline}?**

A sinus infection is a bacterial infection of one of the seven sinuses
that normally drain into the nose. Sinus congestion can occur without an
infection if one of the sinus openings becomes blocked from a cold or
hay fever. It is normal to have sinus congestion from a cold for up to
14 days. If congestion and headache last longer, a sinus infection may
be present.

**[Symptoms]{.underline}**:

1)  pain and pressure above the eyebrow, behind the eye, or over the
    cheekbone

2)  yellow or green nasal discharge

3)  postnasal drip (feeling of something dripping down the back of your
    throat)

4)  fever

5)  bad breath

6)  chronic cough

## Treatment for Sinus Infection

1)  Antibiotic medicine to kill the bacteria. It is [very]{.underline}
    important that you finish the antibiotic to prevent the infection
    coming back.

2\) Tylenol or Ibuprofen for fever and pain relief.

Sinus infections are not contagious but the colds that usually cause
them are.

### TCRHCC 8/05 Revised
![](media/image1.jpeg){width="2.46875in" height="1.1159722222222221in"}

**PARTICIPANT PROFILE**

**Henry W. Fischer**

**PhD, Sociology**

**Director, Center for Disaster Research & Education**

<hfischer@millersville.edu>

 

I enjoy attending the FEMA Higher Education Conference in order to
interact with and learn from others who share our common interest.
Twenty years experience in conducting research into behavioral and
organizational response to disasters and terrorism, has resulted in the
presentation of more than three dozen papers at professional
conferences, the publication of almost two dozen scholarly journal
articles, three books, two monographs, consulting for Research Planning,
Inc./Department of Defense, consulting for the Office of Emergency
Management/Justice Department on TOPOFF2, involvement in the FEMA Higher
Education Project, consulting on the First Responders Project for the
Early Responders Distance Learning Center, appearances on CNN, MS-NBC,
CBC Radio 1, *U.S. News & World Report* and *The Washington Post*,
presentations at international conferences in various European nations.
Professional memberships are held in the International Sociological
Association, the International Research Committee on Disasters, serving
as editor of *UnScheduled Events*, *Contemporary Disaster Review*, and
the internet launch of the *International Journal of Mass Emergencies
and Disasters*, the European Sociological Association, the American
Sociological Association, and the International Association of Emergency
Managers.

Primary expertise is in the behavioral and organizational response to
high consequence events (disasters and terrorism), the role of the media
in high consequence events, as well as developing educational curricula
for delivery in traditional teaching environments and distance
learning/internet based environments. I currently teach Sociology of
Disaster and Sociology of Terrorism, served as Program Coordinator of
the multidisciplinary undergraduate minor in Environmental Hazards &
Emergency Management, and Chair of the pending totally online
multidisciplinary master's degree in emergency management (MSEM). I am
the founder and Director of the Center for Disaster Research & Education
(CDRE). In addition to the director, the CDRE includes an Associate
Director and 13 additional faculty associates from multiple disciplines
from across the university. It also employs a secretary and eight
research assistants. The CDRE is involved in consulting, contract and
grant work. Funding sources have included the Federal Emergency
Management Agency, the Pennsylvania Emergency Management Agency,
Research Planning Inc. (DOD), the Office of Emergency Management/U.S.
Justice Department, the Natural Hazards Center of the University of
Colorado, the First Responders Distance Education Center, and the
National Science Foundation.
**LAST NATIONWIDE FORMULA GRANTS TELECONFERENCE**

**AGENDA**

SEPTEMBER 24, 2008

3:00 -- 4:30 PM Eastern Time

Telephone Number: 877-352-5215

Participant Passcode: 9500563

CSREES/USDA Attendees:

Office of Extramural Programs

Tonya Johnson, Chief, Financial Operations Branch

Brenda Barnett, Budget and Fiscal Specialist, Formula Grants Section

Ellen Danus, Chief, Policy and Oversight Branch

Welcome and Introductions Tonya Johnson

Ellen Danus

Formula Grants Section Tonya Johnson

-Organization and Responsibilities Brenda Barnett

-Status of the FY 2008 Allocation Letters

-Status of the FY 2008 FGO Announcements

-Status of the FY 2008 Formula Grant Applications

-Status of FY 2008 Matching Waivers

-Formula Grant Questions

Policy Section Ellen Danus

-Organization and Responsibilities

-2008 Farm Bill Update

-FY 2009 FGO Process

-Revised Administrative Guidance

-Other Formula Grant Regulations and Policies

Questions and Answers Ellen Danus
DA 00-1773

Released: August 4, 2000

EMERGENCY PETITION FOR FCC COMPLIANCE OVERSIGHT AND CONDITIONAL PETITION
FOR MAXIMUM SANCTIONS

(CC Docket No. 94-102)

*Ex Parte* Status

On July 12, 2000, the Texas Commission on State Emergency Communications
filed an Emergency Petition for FCC Compliance Oversight and Conditional
Petition for Maximum Sanctions, requesting emergency Commission
oversight to facilitate wireless carrier compliance with the
Commission's wireless Enhanced 911 Phase I service rules. Pursuant to 47
C.F.R. § 1.1200(a), this proceeding is designated as a a "permit but
disclose" proceeding and subject to §1.1206 of the Commission's
Rules.[^1] Presentations to or from Commission decision-making personnel
are permissible provided that *ex parte* presentations are disclosed
pursuant to 47 C.F.R. §1.1206(b).

The Texas Commission on State Emergency Communications petition is
available for public inspection during regular business hours in the FCC
Public Reference Room, Room CY-A257, 445 12^th^ Street, S.W.,
Washington, D.C. 20554. Requests should reference: In the Matter of
Emergency Petition of the Texas Commission on State Emergency
Communications for FCC Compliance Oversight Regarding the Six-Month
Deadline for Implementation of Wireless E9-1-1 Phase I Service and
Conditional Petition for Maximum Sactions Against Carriers for
Violations of the FCC's Wireless E9-1-1 Rules Related to those Wireless
Carriers Not Operational by August 31, 2000, CC Docket No. 94-102.

For further information concerning this proceeding, contact Wendy
Austrie, Policy Division, Wireless Telecommunications Bureau at (202)
418-1310.

\- FCC -

[^1]: 47 C.F.R. §1.1206.